Houston, TX, United States of America

Kent L Anderson

USPTO Granted Patents = 5 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2004-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kent L Anderson: Innovator in Gene Therapy

Introduction

Kent L Anderson is a prominent inventor based in Houston, TX, known for his significant contributions to the field of gene therapy. With a total of five patents to his name, Anderson has focused on advancing medical science, particularly in relation to ATP-binding cassette transporters and their implications in macular degeneration.

Latest Patents

Anderson's latest patents include innovative methods of gene therapy utilizing nucleic acid sequences for ATP-binding cassette transporters. These inventions provide crucial nucleic acid and amino acid sequences associated with macular degeneration. Additionally, he has developed methods for detecting agents that modify ATP-binding cassette transporters. This involves combining purified ATP-binding cassette transporters with agents suspected of causing modifications and observing changes in their characteristics. His work also encompasses methods for detecting macular degeneration, further showcasing his commitment to addressing critical health issues.

Career Highlights

Throughout his career, Anderson has been affiliated with prestigious institutions such as Baylor College of Medicine and The Johns Hopkins University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Anderson has worked alongside notable colleagues, including Rando L Allikmets and Michael C Dean. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Kent L Anderson's innovative work in gene therapy and his dedication to advancing medical science make him a significant figure in the field. His contributions continue to pave the way for new treatments and understanding of genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…